...
首页> 外文期刊>Journal of pharmacy practice >Nonchemotherapy Drug-Induced Neutropenia and Agranulocytosis: Could Medications be the Culprit?
【24h】

Nonchemotherapy Drug-Induced Neutropenia and Agranulocytosis: Could Medications be the Culprit?

机译:非化学疗法药物诱发的中性粒细胞减少和粒细胞缺乏症:药物可能是罪魁祸首吗?

获取原文
获取原文并翻译 | 示例

摘要

Drug-induced agranulocytosis is a severe complication that has been implicated with most classes of medications. Medications such as clozapine, trimethoprim-sulfamethoxazole and methimazole have been more commonly associated with agranulocytosis than other agents. Although the pathogenesis isn't fully elucidated, it appears to be two-fold with a direct toxicity to the myeloid cell line and immune-mediated destruction. Patients may be asymptomatic at the time neutropenia is discovered or may present with more severe complications such as sepsis. In approximately 5% of cases drug-induced agranulocytosis may be fatal. Management of drug-induced agranulocytosis includes the immediate discontinuation of the offending medication, initiation of broad-spectrum antibiotics and consideration of the use of granulocyte colony-stimulating factors in high-risk patients.
机译:药物引起的粒细胞缺乏症是一种严重的并发症,与大多数药物类型有关。与氯氮平,其他药物相比,氯氮平,甲氧苄氨嘧啶磺胺甲基异恶唑和甲巯咪唑等药物更常见于粒细胞缺乏症。尽管其发病机理尚未完全阐明,但它似乎具有两倍的作用,对髓样细胞系具有直接毒性并具有免疫介导的破坏作用。发现中性粒细胞减少症时,患者可能没有症状,或者可能出现更严重的并发症,例如败血症。在大约5%的情况下,药物诱导的粒细胞缺乏症可能是致命的。药物引起的粒细胞缺乏症的管理包括立即停止违规用药,开始使用广谱抗生素以及在高危患者中考虑使用粒细胞集落刺激因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号